Fundamental Analysis of Roivant Sciences Ltd - Growth / Value Index


ROIV - Valuation Highlights

Valuation Analysis

   Price to Earning Ratio is 1.99 and EV to EBITDA is -10.01 suggesting company is undervalued.
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 1.97 -6.51 26.87 %
Price to Book 3.58 4.98 36.47 % 1.44
Price to Sales 88.34 285.77 110.06 %
Enterprise Value to EBITDA Multiple -9.91 -5.75 14.53 %


ROIV - Profitability Highlights

Profitability Analysis

   Earning Yield of 50.31 %
   During the past twelve months, the company has given a strong Return On Equity of 221.94%
   During the past twelve months, the company has given a strong Return On Asset of 138.64%
   During the past twelve months, the company has given a strong Net Margin of 4484.41%
   Piotroski F Score - Very Poor Value of 1.0
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 221.94 -106.24 -108.26 % 83.68
Return On Asset 138.64 -51.47 -57.43 % 69.69
Net Profit Margin 4484.41 -4391.22 -187.22 % 13721.55
Operating Profit Margin 4291.06 -3483.89 -42.50 % 13626.50
EBITDA Margin -790.25 -4195.92 -174.56 % -605.22


Highlights
Market Cap9049.65 M
Enterprise Value7800.77 M
Price/Book TTM3.58
Outstanding Share805846 K
Float/ Outstanding Share52.29%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0.660
Peter Lynch Ratio0
Piotroski F Score1.00
Altman Z Score3.86
Sloan Ratio-0.143
Peter Lynch Fair Value0


ROIV - Growth Highlights

Growth Analysis

   YoY Net Margin Jump by 187.22%
   Quarterly sales in last 5 years is trending up
   Tsr Growth Index - Very Poor Score of 11.36
   Companies' sales dropped by 49.33 % from last year
   Company's Total Assets is Decreasing for last 3 years
   Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 99599.00 K 49.33 % 101.58 %
Gross Profit 88451.00 K 67.87 % 120.82 %
EBITDA -787086.00 K 39.11 % 18.69 %
Net Profit 4466.42 M 45.52 % 1774.58 %
EPS 5.70 36.73 % NA


ROIV - Stability Highlights

Stability Analysis

   Altman Z Score of 3.92 suggests good Stability
   Cash ratio of 6.15
   Tsr Stability Index - Poor Score of 28.12
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -42.70
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0.370 176.59 % 0.075
Cash Ratio 6.15 -44.93 %
Quick Ratio 6.59 -43.82 % 27.77
Shareholders Equity 48.45 -24.41 %
Debt to EBITDA -0.364 -38.93 %


Historical Valuation Ratios of Roivant Sciences Ltd

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Roivant Sciences Ltd

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Roivant Sciences Ltd

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Roivant Sciences Ltd

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)